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History
The first indication of prehistoric trepanations was
provided in 1865 when Squier and colleges discovered skulls
of individuals of the pre-Columbian time in whom the surgical
removal of part of the cranium had been performed [27]. The
survival of patients who underwent even multiple
“trephinations” – despite a lack of antibiotics and anesthesia
– was based on evidence of callus formation in patients
from Cuzcu, the capital of the Inca Empire around 1400 AD
[2] (Fig. 1). Half a millennium afterwards, in 1894 Annandale
first introduced the term “decompressive surgery”, and in
1905 Cushing reported on findings of subtemporal and
suboccipital decompression to alleviate increased
intracranial pressure (ICP), mainly as a palliative procedure
in inoperable brain tumors. Cushing predicated this
«subtemporal decompressive operation» an usefulness in
severe head injury which leads to fatal outcome otherwise
[13]. Another thirty years later, Greco for the first time used
decompressive surgery for successful treatment of a patient
with a space-occupying cerebral infarction [31], and it took
until 1968 before the first case series of 9 patients receiving
decompressive surgery (yet 67% surviving) was published
from Greenwood [32].
Clinical syndrome
Patients with subtotal or complete middle cerebral artery
(MCA) infarctions typically present with hemiparalysis,
severe sensory deficits, head- and eye-deviation, hemi-
inattention, and, if the dominant hemisphere is involved,
global aphasia [36, 63]. Within 24-48 hours patients usually
continuously deteriorate in their level of consciousness
based on the commonly associated serious brain swelling
evolving within 1-5 days after stroke [18, 28]. The resulting
increased ICP leads to further destruction of formerly healthy
brain tissue that is why the term “malignant MCA infarction”
was proposed [39]. These large cerebral infarctions often
result in severe shifting of midline structures with
subsequent uncal or even transtentorial herniation [58] and
were attributed an extremely poor prognosis in over 80% of
cases [45, 48, 52, 69]. Over decades the treatment of malignant
MCA infarction remained a major unsolved problem in
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neurocritical care [28, 57]. Several pharmacological treatment
approaches such as osmotic therapy, steroids,
hyperventilation, barbiturates, and buffers have been
proposed to reduce cerebral edema formation, but up to now
none of these therapeutic strategies was supported by
adequate evidence of efficacy from clinical trials [4, 10, 35].
Finally, between 2006 and 2009 data from randomized trials
were published providing a clear evidence of a dramatic
reduction in mortality of patients who underwent
decompressive surgery (so-called hemicraniectomy) for
treatment of space-occupying MCA infarction.
Pathophysiology
The pathophysiological processes that lead to a
malignant MCA infarction are not yet completely discovered.
Generally, a critical reduction of the cerebral blood flow of
less than 40% of regular values results in a collapse of
membrane potential with consecutive loss of electric
functionality of neurons [65]. Brain tissue with perfusion
levels below the threshold for structural integrity will
irreversibly die. The discontinuation in supply of oxygen
and substrate leads to metabolic-based reduction of
adenosine-triphosphate (ATP) levels, latter being already
completely exhausted after  ~10-20 minutes. As a
consequence of loss of energy, on one hand the reuptake of
the excitatory amino-acid glutamate into the presynaptic
astrocytes is deranged, and on the other hand its release
into the extracellular space increased because of cell
depolarization based on dysfunctional ATP-dependent ion
pumps. Scientific approaches using microdialysis identified
this raised glutamate to be a very early mediator of ischemia
[6, 49, 61]. Moreover, cortical spreading depression and
depolarization of peri-ischemic brain tissue may occur and
further leads to imbalances of glutamate levels [16]. The
elevated glutamate level itself accounts for an increased influx
of potassium by activation of voltage-dependent potassium
channel and glutamate-NMDA/AMPA receptors. A hyper-
excitatory snowball effect of vice versa induced glutamate
release and potassium overload leads to further calcium-
dependent harms and deregulation of the neuronal NO-
synthesis resulting in both raised levels of free radicals and
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pathological genes expression and DNA fragmentation [23,
37]. The intracellular calcium-burst activates calpains that
destruct the cytoskeleton, the structural protein spectrin,
and the microtubule [42]. Taken together, the ischemic
cascade mainly constitutes of (i) excitatory phase, followed
by (ii) peri-ischemic depolarizations that lead to (iii)
inflammation, and finally (iv) apoptosis [17].
CT and MR imaging
Cranial computed tomography (CT) is widely used
for diagnosis and monitoring of patients with
malignant MCA infarction [11, 46, 63] (Fig. 2).
However, as repeated CT imaging within the first days
may be necessary to demonstrate the definite area of
infarction, various studies concentrate on
identification of parameters for an early prediction of
a malignant course using multi-slice CT, CT-
angiography and -perfusion [1, 46]. In this regard,
magnetic resonance imaging (MRI) may be of
advantage especially in earlier stages of the disease
[50, 51]. Generally, a neuroradiological definition of a
malignant MCA infarction assumes that at least two
thirds of the MCA territory are affected. Other authors
predict a severe edema formation even if more than
50% of the rostral MCA territory with involvement of
the basal ganglia show ischemic alterations [16, 51].
Additionally, infarctions of the ipsilateral anterior or
posterior cerebral arteries may occur. The definite infarction
volume on MRI is evident as hyper-intense lesions on FLAIR
sequences, however, in the hyper-acute stages even
diffusion-weighted sequences (DWI) reliably predict a
malignant MCA infarction if the lesion volume exceeds 145
cm3 [67].
Figure 1. From history to modernity.
(A) Rectangular incised trepanation observed in an old adult Inca woman. The cutmarks did not show signs of healing such as
remodeling or reactive bone, leading to the conclusion that the individual did not survive the trepanation procedure. (B) Example
of an Inca individual who underwent circular trepanation with signs of healing thereafter. (C) Picture of Inca trepanation. (D)
Intra-operative view on strained dura after removal of the bone flap during hemicraniectomy.
Figure 2. Brain imaging findings before and after hemicraniectomy
in malignant MCA infarction
(A) Axial cranial computed tomography 24h after symptom onset. (B)
Axial diffusion-weighted magnetic resonance tomography in the
acute phase of malignant MCA infarction. (C) Axial computed
tomography of another patient with left-sided malignant MCA
infarction 2 days after hemicraniectomy showing outward swelling of
the ischemic brain tissue.
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Conservative treatment
Patients with large space-occupying MCA infarctions
require immediate intensive care in a specialized neurocritical
care unit. Sedation, intubation and mechanical ventilation
appear indicated early and even electively once the malignant
course of the disease has been verified to prevent aspiration
and to start invasive treatment [4, 41]. There is a wide variety
of pharmacological treatment approaches for prevention and
management of the developing brain edema [4].
Administration of osmotic agents, mannitol, glycerol, and
hypertonic saline reduces increased ICP and seems to be
likely to impact outcome but their efficacy has not been
proven in randomized clinical trials yet [4, 10]. Unfortunately,
all other approaches, such as barbiturates, hyperventilation,
head elevation, THAM (Trishydroxymethylaminomethane)
buffer, indomethacin, steroids, and furosemide were not
supported by adequate evidence of efficacy and may even
be detrimental [3, 4, 62, 66]. Case series on outcome of patients
with malignant MCA infarctions who received maximum
conservative treatment did not report significant clinical
impact of those procedures [39, 45].
Moderate hypothermia, achieved with endovascular
catheters and target temperatures between 33-35°C,
represents a promising approach for neuroprotection in
patients with large MCA infarctions [7, 60]. Hypothermia
reduces the cerebral metabolic rate and stabilizes the blood-
brain barrier. Reduction of free radicals formation and release
of excitatory neurotransmitters results in less brain edema
formation, and attenuates the postischemic inflammatory
response and apoptosis [30]. Besides various encouraging
animal studies that confirmed these findings, clinical
observational studies demonstrated a reduced mortality and
a good outcome of the surviving patients [21, 26, 29, 30, 43,
47, 59, 70]. In light of a strong association of fever and poorer
outcome after stroke [8], these encouraging data on
hypothermia however, have to be considered as preliminary
findings as up to now there is no evidence from randomized
trials on cooling in treatment of malignant MCA infarction.
Hemicraniectomy
Surgical techniques and observational clinical studies.
Key idea of decompressive surgery is to remove part of the
cranium to allow outward swelling of ischemic brain tissue
without compromising healthy brain areas by midline shift
and ventricular compression [15, 22]. The consecutive
“normalizing” of increased ICP levels results in raised cerebral
blood flow and improved cerebral perfusion pressure that
leads to better oxygenation of yet healthy brain tissue [5, 10,
38]. Decompressive surgery is based on a hemicraniectomy
in combination with a duraplasty [22]. A question mark-
shaped skin incision is followed by removal of a bone flap
that at least has a diameter of 12 cm including parts of the
frontal, parietal, temporal, and occipital squama [9, 56]. After
opening of the dura a dural patch is inserted which usually
consists of homologous periost or of a temporal fascia.
Ischemic brain tissue is not resected. An ICP probe may be
inserted for further monitoring. After 6 weeks and up to 6
months the stored or an artificial bone flap is used for
reconstituting cranioplasty [34].
A wide majority of clinical observational studies were
able to confirm the experimental data on a reduced mortality
of patients who underwent decompressive surgery.
Admittedly, some trials compared their results to historical
patients and lots of the control patients suffered from severe
co-morbidity or were of older age. The findings regarding
functional outcome and quality of life remain arguable.
Several risk factors that predict mortality and poor functional
outcome were identified, age being the strongest one,
followed by a low Glasgow coma scale score on admission,
involvement of other than the MCA territory, presence of
anisocoria, early clinical deterioration, presence of coronary
artery disease, and internal carotid artery occlusion [14, 20,
24, 25, 33, 40, 44, 48]. Unfortunately, there are only few data
on the long-term outcome and quality of life of patients who
received hemicraniectomy [12, 53-55, 68].
Randomized clinical trials on hemicraniectomy. Three
European trials (i) Decompressive Surgery for the Treatment
of Malignant Infarction of the Middle Cerebral Artery
(DESTINY) [16], (ii) Decompressive Craniectomy in
Malignant Middle Cerebral Artery Infarcts (DECIMAL) [67],
and (iii) Hemicraniectomy After Middle Cerebral Artery
Infarction with Life-threatening Edema Trial (HAMLET) [64]
have been published recently. In addition, in 2007 a pooled
analysis of DECIMAL, DESTINY, and 23 patients of the
ongoing at that time HAMLET trial were published [19].An
updated meta-analysis after completion of HAMLET in 2009
was published[64].
The German DESTINY trial was an open, controlled,
prospective, randomized, multicenter study that included
patients with a malignant MCA infarction younger than 60
years of age and within 36 hours after symptom onset.
Patients were randomized to either surgical plus best medical
treatment or to best conservative treatment alone excluding
hypothermia. DESTINY was based on a sequential design:
as a first endpoint mortality after 30 days was assessed, and
randomization was planned to go on until a statistical
significance for this endpoint was reached. Patient
enrollment would then be interrupted until data of the primary
endpoint (dichotomized 6-months functional outcome
according to the modified Rankin Scale (mRS) 0-3 versus 4-
6) had been collected. Depending on the observed difference
in functional outcome, the final sample size would be
recalculated for a second explorative trial stage. As a
secondary endpoint dichotomization of patients into those
who reached mRS 0-4 after one year versus those who
showed a mRS of 5-6 was planned. A statistically significant
difference in mortality was seen after inclusion of 32 patients.
The “Intention to treat”-analysis revealed that the 30 days-
mortality was 12% (2/17) in the hemicraniectomy arm and
47% (7/15) in the conservative treatment group (p=0.02).
The consecutive functional outcome analysis did not show
significant differences (47% of the patients in the surgical
arm versus 27% in the conservative treatment group reached
a mRS of 0-3; p=0.23). Indeed, the secondary outcome
comparison revealed a significant difference in favour of
surgical treatment (76.5% in the surgical arm versus 33.3% of
conservatively treated patients reached a mRS of 0-4; p=0.01),
as did the distribution of the mRS scores (p=0.04). After
calculation of a sample size for attaining the primary endpoint
(necessity of at least 188 randomized patients), DESTINY
was stopped because of ethical concerns [16].
The French DECIMAL trial was similarly resigned and
included patients younger than 55 years of age within 30
hours after symptom onset. The primary endpoint in
DECIMAL was functional outcome based on the score on
the mRS, dichotomized 0-3 versus 4-6 and interim analyses
after every four patients. Secondary endpoints included
survival and mRS at 6 and 12 months. After randomization of
38 patients the data safety monitoring committee
recommended discontinuation of the study because of a
planned pooled analysis with the other European trials. At
that time-point there was a significant difference in survival
(5/20 patients (25%) who received hemicraniectomy versus
14/18 patients (78%) treated conservatively (p<0.01) had
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died, reflecting an absolute risk reduction of more than 52%).
The functional outcome analysis failed to reach significance
both in the 6- (mRS ?3 in 25% versus 5.6%; p=0.18) and 12
months follow-up examination (mRS ?3 in 50% versus 22.2%;
p=0.10) [67].
The Dutch HAMLET trial included patients younger
than 60 years of age within 96 hours after symptom onset.
The primary endpoint was the functional outcome after 12
months, dichotomized according the mRS (0-3 versus 4-6).
Besides others, secondary endpoints were case fatality and
a dichotomized functional outcome analysis (mRS 0-4 versus
5-6). After obtaining the 1-year follow-up outcome data of
50 patients (at that time 64 patients had been recruited), the
data monitoring committee recommended discontinuation
of the trial as it appeared unlikely to reach significance for
the primary outcome measure. Also the secondary outcome
measure was negative with respect to functionality on the
mRS. However, surgical decompression showed a clear
reduction in mortality (21.8% versus 59.3%; p=0.002) with an
absolute risk reduction of 38% [64].
Pooled analysis and meta-analysis of DECIMAL,
DESTINY, and HAMLET. In 2007 the results of a pooled
analysis of the three European trials (DESTINY, DECIMAL,
and 23 patients from HAMLET) were published [10]. For
this prospectively planned pooled analysis a maximum “time
window” from stroke onset to treatment of 48 hours was
adopted. Outcome measures were mortality and functional
outcome (mRS) at one year, dichotomized into a mRS of 0-3
versus 4-6, and 0-4 versus 5-6, respectively. Of 93 patients
analyzed 51 had received hemicraniectomy and 42 had been
assigned to conservative treatment. There was a significantly
lower case fatality rate in the surgical group than in the
conservative treatment arm (29% versus 78%; p<0.01) with
an absolute risk reduction of 50%. Regarding the functional
outcome, the pooled analysis demonstrated that patients
who underwent decompressive surgery significantly more
often reached both a mRS ?3 (43% versus 21%; p=0.014;
absolute risk reduction of 23%), and a mRS ?4 (75% versus
24%; p<0.01; absolute risk reduction of 51%). These data
were the basis of a calculation of the numbers needed to
treat (NNT). (i) the NNT for survival was 2, irrespective of
functional outcome, (ii) the NNT for a mRS ?3 was 4, and (iii)
the NNT for a mRS ?4 was 2. This positive effect of surgery
was moreover highly consistent across the three trials.
However, there was no difference in the benefit of surgery
for neither of predefined subgroups (i) age (above and below
50 years), (ii) presence of aphasia, and (iii) time to
randomization (within or beyond 24h) [10].
After completion of HAMLET in 2009, an updated meta-
analysis including all patients of DESTINY, DECIMAL, and
HAMLET who were randomized within 48 hours after stroke
onset focussed on case fatality rate and functional outcome
after 12 months [68]. Of altogether 109 patients analyzed, 58
had been assigned to surgery and 51 to conservative
treatment. With respect to mortality, the absolute risk
reduction achieved with surgical decompression compared
to conservative treatment alone was 49.9% (95%-confidence
intervals (CI): 33.9-65.9), confirming the previously reported
NNT of 2 for prevention of death. There was an absolute
risk reduction of 41.9% (CI: 25.2 to 58.6) for an outcome
measure mRS >4 when being treated with hemicraniectomy,
reflecting a NNT of 2. Yet, the functional outcome analysis
of those patients who reached a mRS of three and less
revealed a non significant benefit of surgical decompression
(23/58 (39.6%) versus 12/51 (23.5%); absolute risk reduction
of 16.3% (-0.1-33.1), corresponding to a NNT of 6 patients)
(Fig. 3).
Open questions and conclusion
Despite the dramatic improvement in the survival rate of
patients who received surgical decompression instead of
conservative treatment, there remain some important issues
that need to be addressed in the future. They include (i) a
potential age limit for surgical decompression (currently
analyzed in the DESTINY II trial), (ii) whether patients with
involvement of the dominant hemisphere should be operated
on, (iii) and the exact time-point of surgery, and accordingly
whether a cut-off time exists after which surgery would not
be beneficial any longer. Taken together, the three European
prospective randomized trials and the pooled-analyses
revealed a dramatic increase in survival by decompressive
surgery. However, several clinical and ethical questions
remain that need to be resolved in future studies.
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